What Are the Benefits of Testosterone Replacement Therapy?

Testosterone replacement therapy produces measurable improvements in body composition, sexual desire, mood, and metabolic markers in men with clinically diagnosed low testosterone. The size and consistency of those benefits vary by domain: fat loss and lean mass gains show up reliably in trials, libido improvements are well documented, and depressive symptoms tend to ease, while effects on things like erectile function and cognition are more modest or inconsistent. The therapy also carries real trade-offs that anyone considering it should understand before starting.

How Low Testosterone Gets Diagnosed

Before the benefits make sense, it helps to know who actually qualifies. The American Urological Association defines low testosterone as a total testosterone level below 300 ng/dL, confirmed on two separate early-morning blood draws, combined with symptoms like fatigue, low sex drive, or loss of muscle mass.¹ That last part matters: a number alone does not earn a diagnosis. A man with a testosterone level of 280 ng/dL who feels fine and functions normally would not typically be started on therapy. It is the combination of low levels and symptoms that triggers treatment.

Testosterone levels also decline naturally with age, starting as early as the twenties and thirties. This age-related decline is not the same thing as classical hypogonadism caused by diseases of the hypothalamus, pituitary, or testes. In younger men with clear-cut causes of deficiency, the case for replacement is strong and the benefits well established. In older men experiencing a gradual slide, the picture is less straightforward, and the question of whether treatment is warranted requires weighing the individual’s symptoms against the risks.²

Body Composition Changes

If there is one area where TRT delivers reliably, it is shifting the ratio of fat to lean tissue. In a 36-month trial of men over 65, testosterone treatment produced roughly 2 kg more lean mass gain and 2.3 kg more fat loss than placebo, with the fat coming off primarily from the arms and legs and the lean mass accruing mostly in the trunk.³ In obese men dieting to lose weight, adding testosterone preserved lean mass during the maintenance phase. The placebo group lost lean tissue and did not regain it, while the testosterone group regained about 3.3 kg of lean mass after the initial weight-loss phase, resulting in roughly 3.4 kg more lean tissue retained at the end of the study.⁴

The gains are dose-dependent and amplified by exercise. A case report tracking body composition across TRT phases found that lean mass increased about 6% in the first phase and continued climbing in the second, while body fat percentage dropped in both phases, with regular aerobic and strength training several times per week enhancing the results.⁵ That finding lines up with what clinicians generally observe: testosterone on its own shifts body composition, but pairing it with resistance and aerobic training produces noticeably larger changes.

One important caveat from that same 36-month trial in older men: despite gaining lean mass, the testosterone group did not get stronger on knee extension and flexion tests compared to placebo.³ More muscle tissue on your frame does not automatically translate into more functional strength, especially in older adults who may need structured resistance training to activate those gains.

Sexual Desire and Erectile Function

Improved libido is probably the benefit men hear about most, and the evidence backs it up, with qualifications. A meta-analysis of available studies found that testosterone treatment moderately improved sexual thoughts, motivation, and overall sexual satisfaction in men whose baseline testosterone was below about 12 nmol/L (roughly 346 ng/dL), but had no effect on erectile function in men who started with normal levels.⁶ A more recent meta-analysis of placebo-controlled trials found that TRT produced statistically significant but small improvements in sexual desire, erectile function scores, and sexual satisfaction.⁷

The pattern that emerges across studies is that libido is the most responsive domain. A large randomized trial found TRT improved sexual desire and general hypogonadal symptoms but not erectile function compared to placebo.⁸ Where erectile difficulty is mild, testosterone can help, and it may improve responses to PDE5 inhibitors (drugs like sildenafil) in men who were not responding to those medications alone.⁹ But for men with severe erectile dysfunction, testosterone alone is unlikely to fix the problem, because the causes at that stage are usually vascular or neurological rather than purely hormonal.

There is also a ceiling effect worth knowing about: once testosterone levels reach the normal range, pushing them higher does not keep improving libido. The benefit plateaus at normalization.⁹ And the effect on erectile function in particular tends to decline over time.⁶

Mood and Depressive Symptoms

A meta-analysis of 27 randomized controlled trials involving nearly 1,900 men found that testosterone treatment produced a meaningful reduction in depressive symptoms compared to placebo, with treated men having roughly twice the odds of experiencing symptom improvement.¹⁰ Quality of life in older hypogonadal men also improves with treatment, as shown in large placebo-controlled trials.¹¹

That said, the same systematic meta-analysis of TRT trials that found benefits for sexual desire found no significant effect on energy or mood overall.⁷ The discrepancy probably reflects the difference between men with clear depressive symptoms at baseline (who tend to respond well) and more general populations (where the mood benefit gets diluted). If you are hypogonadal and dealing with genuine low mood, the evidence suggests TRT can help. If your mood is fine and you are just hoping for a boost, the data is less encouraging.

Fatigue and Energy

Chronic fatigue is one of the most common complaints among men with low testosterone, and TRT appears to make a real dent. In a study comparing hypogonadal men on treatment for over a year against untreated controls, the treated group scored substantially lower on a fatigue severity scale, with therapy associated with about a 15-point drop in fatigue scores after adjusting for age and other factors.¹² In frail older men, combining testosterone with resistance training reduced fatigue and tiredness significantly compared to controls, while testosterone or exercise alone did not produce the same result.¹³

That combination finding keeps surfacing throughout the TRT literature: testosterone sets the stage, but exercise is often what locks in the improvement. A study of men with HIV-related weight loss found that supraphysiological testosterone doses increased fat-free mass significantly but did not clearly improve fatigue or energy measures on their own, though the improvements were described as clinically meaningful and in need of further confirmation.¹⁴ The takeaway: TRT can meaningfully reduce fatigue in hypogonadal men, but it works best as part of a broader approach that includes physical activity.

Metabolic Health

Low testosterone and metabolic syndrome tend to travel together, and raising testosterone levels in hypogonadal men appears to improve several metabolic markers. In men with type 2 diabetes and low testosterone, replacement therapy reduced insulin resistance (measured by the standard HOMA index), lowered fasting blood glucose, and modestly reduced glycated hemoglobin, a marker of long-term blood sugar control. Waist circumference and total cholesterol also dropped.¹⁵ A larger trial, TIMES2, found that TRT reduced insulin resistance by about 15% at six months and 16% at 12 months, with better blood sugar control in diabetic patients emerging by nine months.¹⁶

These metabolic improvements are intertwined with the body composition changes: less visceral fat tends to improve insulin sensitivity on its own, so it can be hard to tell how much of the metabolic benefit comes from testosterone directly versus from the downstream loss of abdominal fat.¹⁷ Either way, for men with both low testosterone and metabolic dysfunction, the evidence points in a consistently positive direction.

Bone Density Without Fewer Fractures

This is where the evidence gets genuinely puzzling. TRT clearly improves bone density. A two-year randomized trial found that testosterone increased bone mineral density at the spine and hip, thickened cortical bone at the wrist and shin, and reduced bone-turnover markers, all of which should, in theory, mean stronger bones.¹⁸

Yet when researchers looked at actual fractures in the TRAVERSE trial, which followed men for over three years, fractures were not reduced. In fact, the testosterone group had a higher rate of clinical fractures than the placebo group.¹⁹ A meta-analysis of randomized trials confirmed that pattern: overall clinical fracture risk was higher with TRT, though the difference disappeared when looking specifically at major osteoporotic fractures (hip, spine, wrist, and arm), where rates were similar between groups.²⁰

The disconnect between better density numbers and more fractures remains unexplained. One possibility is that the types of fractures driving the increase are non-osteoporotic (think falls, trauma) rather than the fragility fractures that bone density is supposed to predict. Another is that testosterone’s effects on balance, activity levels, or risk-taking behavior could confound the picture. Whatever the explanation, you should not start TRT expecting it to protect you from broken bones. The density improvements are real; the fracture protection is not.

Cognitive Function

Many men with low testosterone report brain fog, and it is natural to wonder whether TRT could sharpen thinking. The honest answer is that the evidence is disappointing. In the Testosterone Trials, a well-designed study of nearly 500 older men with age-associated memory impairment and low testosterone, one year of treatment produced no significant improvement in delayed recall, visual memory, executive function, or spatial ability compared to placebo.²¹

A smaller study found that men who already had significant cognitive impairment at baseline (scores below 25 on a cognitive function test) did improve with TRT.²² And a review noted that long-term TRT could potentially improve specific domains like verbal memory and cognitive flexibility, but that randomized controlled trials mostly do not support a clear benefit.²³ If you are hoping TRT will make you sharper, it probably will not, unless you have notably impaired cognition to begin with.

Cardiovascular Safety

For years, the biggest worry about TRT was heart risk. That question has been largely answered by the TRAVERSE trial, the biggest randomized cardiovascular safety study of testosterone to date. It found that the rate of major cardiovascular events (heart attack, stroke, or cardiovascular death) was essentially the same in the testosterone and placebo groups.²⁴ A review of the trial’s long-term implications confirmed no increase in major adverse cardiac events or prostate-related events.²⁵

The Androgen Society, in a position paper responding to this evidence, went further, stating that it has now been “conclusively determined” that TRT does not increase the risk of heart attack, stroke, or cardiovascular death, citing TRAVERSE alongside multiple additional randomized trials, large observational studies, and 19 meta-analyses reaching similar conclusions.²⁶

That is not a clean bill of health for every system, though. TRAVERSE did find a higher incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group.²⁴ These are not trivial conditions, and they deserve monitoring even though the major cardiac endpoints came out clean.

Prostate Safety

The old fear that testosterone fuels prostate cancer has not held up. In the TRAVERSE trial, rates of high-grade prostate cancer, any prostate cancer, urinary retention, invasive procedures, and biopsies did not differ meaningfully between the testosterone and placebo groups, though PSA levels rose more in treated men.²⁷ A separate systematic review and meta-analysis found no statistically significant increase in prostate cancer risk with any route of testosterone administration, and confirmed that short-term TRT does raise PSA levels compared to placebo.²⁸ The PSA rise is typically modest and reflects increased prostate gland activity rather than malignancy, but it means you need regular PSA monitoring while on therapy so that any meaningful change can be caught early.

Fertility Is a Major Trade-Off

This is the benefit-versus-cost issue that catches the most men off guard. Exogenous testosterone suppresses the hormonal signals that drive sperm production. When you take testosterone from outside the body, the brain senses adequate levels and dials down the release of the hormones that tell the testes to make sperm.²⁹ The result is a dose-dependent suppression of sperm output that can, in some men, approach zero.³⁰

If you want children now or in the near future, standard TRT is generally not the right option. Alternatives like clomiphene citrate or human chorionic gonadotropin can raise testosterone while preserving fertility. Any prescriber worth trusting will ask about family planning before writing a testosterone prescription.

Blood Thickening and Other Side Effects

The most common laboratory side effect of TRT is a rise in red blood cell production, which at extreme levels is called erythrocytosis. Men on TRT have a roughly threefold greater risk of developing elevated hematocrit levels compared to untreated men.³¹ Thicker blood can increase the risk of clotting events, which is why routine blood work monitoring hematocrit is standard during therapy.

The risk varies by formulation. A study comparing gels, injections, and pellets over three years found that injectable testosterone produced erythrocytosis in about two-thirds of men, compared to roughly a third for pellets and about one in eight for gels.³² Injections also produce higher peak testosterone levels and larger swings between doses, which likely drives the higher red blood cell response. Gels deliver steadier, more moderate levels, while pellets fall somewhere in between. None of these delivery methods perfectly mimic the body’s natural daily rhythm of testosterone production.³³

What Happens When You Stop

TRT is generally not a course of treatment with a defined end date. When hypogonadal men stopped therapy in one study, testosterone fell back to deficient levels, and the improvements they had experienced in weight, sexual function, voiding symptoms, and symptom scores reversed until treatment was restarted.³⁴ The authors concluded that hypogonadism may require lifelong treatment.

Beyond symptom rebound, the body’s own hormone production needs time to recover. After two years of injectable testosterone undecanoate, full recovery of reproductive hormones took about 15 months after the final injection and may take even longer in some men.³⁵ If you are considering TRT, understanding that it is likely an ongoing commitment and not a short course is an important part of the decision.

The Cost of Getting Started

Access and affordability vary wildly depending on how and where you get treatment. Direct-to-consumer telemedicine platforms that have proliferated in recent years charge substantially more than traditional medical settings. A comparison study found that 12 months of intramuscular testosterone through telemedicine platforms ranged from about $1,600 to $4,200, while the same treatment through a tertiary medical center ranged from roughly $134 to $1,333 depending on insurance coverage.³⁶ The convenience of a telemedicine app may come at a steep premium, and some of these platforms have been criticized for loose diagnostic standards. Getting your workup through a primary care physician or endocrinologist and filling a prescription at a pharmacy is usually far cheaper and comes with the clinical oversight that ongoing monitoring demands.

1
The Journal of Urology. Evaluation and management of testosterone deficiency: AUA guideline
2
Nature Reviews Endocrinology. Risks and benefits of testosterone therapy in older men
3
PubMed. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age
4
PubMed Central. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial
5
PubMed Central. Dose-Response Effects of Exercise and Testosterone Replacement Therapy on Body Composition, Lean Mass, and Heart Rate Responses: A Case Report Using Wearable Technology
6
PubMed. Effects of testosterone on sexual function in men: results of a meta-analysis
7
Oxford Academic (The Journal of Clinical Endocrinology & Metabolism). The Efficacy and Adverse Events of Testosterone Replacement Therapy in Hypogonadal Men: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials
8
PubMed. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism
9
PubMed Central. Testosterone Therapy Improves Erectile Function and Libido in Hypogonadal Men
10
JAMA Psychiatry. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis
11
PubMed. Testosterone, mood, behaviour and quality of life
12
PubMed Central. Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
13
PubMed. Testosterone and resistance training improved physical performance and reduced fatigue in frail older men: 1 year follow-up of a randomized clinical trial
14
PubMed. Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss
15
PubMed. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
16
PubMed Central. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)
17
PubMed Central. Testosterone and the metabolic syndrome
18
The Journal of Clinical Endocrinology & Metabolism. Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT
19
PubMed. Testosterone Treatment and Fractures in Men with Hypogonadism
20
PubMed. Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials
21
JAMA. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment
22
PubMed Central. Effect of Testosterone Replacement Therapy on Cognitive Performance and Depression in Men with Testosterone Deficiency Syndrome
23
PubMed Central. Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition
24
PubMed. Cardiovascular Safety of Testosterone-Replacement Therapy
25
PubMed Central. Long Term Cardiovascular Safety of Testosterone Therapy: A Review of the TRAVERSE Study
26
PubMed. Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy
27
JAMA Network Open. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial
28
Prostate Cancer and Prostatic Diseases. The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis
29
PubMed Central. Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility
30
The Journal of Clinical Endocrinology & Metabolism. Effects of Chronic Testosterone Administration in Normal Men: Safety and Efficacy of High Dosage Testosterone and Parallel Dose-Dependent Suppression of Luteinizing Hormone, Follicle-Stimulating Hormone, and Sperm Production
31
Sexual Medicine Reviews. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male
32
PubMed Central. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
33
PubMed Central. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age
34
PubMed. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters
35
European Journal of Endocrinology. Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections
36
Oxford Academic (The Journal of Sexual Medicine). Practice Comparison and Cost Analysis of Direct-to-Consumer Telemedicine Platforms Offering Testosterone Therapy